TP53 and melanoma: Using the combinatorial GAL4-UAS system, a cross between a driver line containing the transactivator GAL4 under the kita promoter, and a responder line expressing human HRASG12V, Mione’s lab developed a p53-independent melanoma model, that give rise to melanoma by 1–3 months of age [73].